Advertisement

Human Physiology

, Volume 41, Issue 1, pp 104–108 | Cite as

Estimation of the parameters of the renin-angiotensin-aldosterone system, water-electrolyte metabolism, and endothelial function in newborns of women with chronic hypertension

  • G. N. ChistyakovaEmail author
  • I. A. Gazieva
  • I. I. Remizova
Article
  • 43 Downloads

Abstract

The parameters of the renin-angiotensin-aldosterone system (RAAS), natriuretic peptides, and markers of endothelial function in the early neonatal period and at an age of three months were estimated in 83 full-term infants of women with chronic hypertension, including 60 newborns of women with chronic hypertension of mild to moderate severity (the main group) and 23 newborns of women without hypertension (the comparison group). The levels of renin, angiotensin-II, aldosterone, natriuretic peptides, and endothelin-1 in the umbilical cord and peripheral blood were determined by enzyme-linked immunosorbent assay (ELISA); those of stable metabolites of nitrogen, by the Griess method. Newborn of women with chronic hypertension exhibited a significant elevation of the renin, angiotensin II, and brain natriuretic peptide levels at birth. A statistically significant increase in the concentration of atrial natriuretic peptide (ANP1–28) was detected in these infants on the third to fifth day of life. In addition, the infants of this group have significantly higher levels of renin, angiotensin II, and endothelin-1 and decreased levels of endogenous nitrite at the age of three months. The results of our study indicate prenatal activation of the RAAS in the fetus. The elevated RAAS activity persisted in infants of women with chronic hypertension during the first three months of life and endothelial dysfunction in these infants developing by the age of three months.

Keywords

newborns endothelial dysfunction renin angiotensin II 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Diagnostika i lechenie arterial’noi gipertenzii u beremennykh. Klinicheskie rekomendatsii (Diagnosis and Treatment of Hypertension in Pregnancy: Clinical Recommendations), Moscow: Vserossiiskoe Nauchnoe Obshchestvo Kardiologov, Rossiiskoe Meditsinskoe Obshchestvo po Arterial’noi Gipertonii, 2010, p. 84.Google Scholar
  2. 2.
    Roberts, C.L., Algert, C.S., Morris, J.M., et al., Hypertensive disorders in pregnancy: a population-based study, Med. J. Australia, 2005, vol. 182, no. 7, p. 332.PubMedGoogle Scholar
  3. 3.
    Jesuino, F.A., Casqueiro, J.B., and Moreira, L.M.O., Study on the prevalence of arterial hypertension in mothers of low birth weight newborns, Einstein, 2006, vol. 4, no. 4, p. 298.Google Scholar
  4. 4.
    Smirnov, I.E., Shakina, L.D., Rivne, Y., et al. Endothelial dysfunction in hypoxic-ischemic brain damage in infants, Russ. J. Pediatr., 2010, vol. 4, p. 32.Google Scholar
  5. 5.
    Beer, M., Vrijkotte, T.G.M., Wal, M.F., et al., Relation of maternal hypertension with infant growth in a prospective birth cohort: the ABCD study, J. Dev. Orig. Health Dis., 2010, vol. 1, no. 5, p. 347.CrossRefPubMedGoogle Scholar
  6. 6.
    Nosikov, V.V., Tereshchenko, S.N., Zateyschikov, D.A., et al., Gene polymorphism of angiotensin converting enzyme, angiotensin II, NO-synthase, and estrogen receptor and gender differences in their influence on the development of cardiovascular disease, Kardiologiya, 2009, vol. 4, p. 58.Google Scholar
  7. 7.
    Khamidullaeva, G., Kevorkov, A., and Eliseyeva, M., Genetic aspect of endothelium dysfunction in Uzbek hypertensive patients, MHSJ, 2010, vol. 4, p. 30.CrossRefGoogle Scholar
  8. 8.
    Balam-Ortiz, E., Esquivel-Villarreal, A., Huerta-Hernandez, D., et al., Hypercontrols in genotype-phenotype analysis reveal ancestral haplotypes associated with essential hypertension, Hypertension, 2012, vol. 59, p. 847.CrossRefPubMedCentralPubMedGoogle Scholar
  9. 9.
    Chatsuriyawong, S., Gozal, D., Kheirandish-Gozal L., et al. Genetic variance in nitric oxide synthase and endothelin genes among children with and without endothelial dysfunction, J. Transl. Med., 2013, vol. 11, p. 227.CrossRefPubMedCentralPubMedGoogle Scholar
  10. 10.
    Shishkin, A.N. and Lyndin, M.L, Endothelial dysfunction and hypertension, Arter. Gipert., 2008, vol. 14, no. 4, p. 315.Google Scholar
  11. 11.
    Versari, D., Daghini, E., Virdis, A., et al., Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br. J. Pharmacol., 2009, vol. 157, no. 4, p. 527.CrossRefPubMedCentralPubMedGoogle Scholar
  12. 12.
    Gafarova, F.M., The state of carbohydrate metabolism and its relationship with the level of nitric oxide (NO) in the blood of newborns with increased perinatal risk, Pediatriya, 2009, vol. 87, no. 4, p. 158.Google Scholar
  13. 13.
    Kaur, C., Sivakumar, V., Ang, L.S., and Sundaresan, A., Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity, J. Neurochem., 2006, vol. 98, no. 4, p. 1200.CrossRefPubMedGoogle Scholar
  14. 14.
    Popova, I.G., Laboratory evaluation of endothelial function in term infants born to mothers with preeclampsia, Klin. Lab. Diagn., 2009, vol. 6, p. 12.PubMedGoogle Scholar
  15. 15.
    Afonin, A.A., Strogulin, V.V., Loginov, I.G., et al., Dynamics of cerebral hemodynamics and endothelium factors of its regulation in children with perinatal CNS disease in the first year of life, Pediatriya, 2011, vol. 90, no. 1, p. 30.Google Scholar
  16. 16.
    Armstead, W.M. and Raghupathi, R., Endothelin and the neurovascular unit in pediatric traumatic brain injury, Neurol. Res., 2011, vol. 33, no. 2, p. 127.CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Kumar, A., Mittal, R., Khanna, H.D, and Basu, S., Free radical injury and blood-brain barrier permeability in hypoxic-ischemic encephalopathy, Pediatrics, 2008, vol. 122, no. 3, p. 722.CrossRefGoogle Scholar
  18. 18.
    Tsyvian, P.B., Markova, T.V., Mikhailova, S.V., et al., Left ventricular isovolumic relaxation and renin-angiotensin-aldosterone system in the growth restricted fetus, Eur. J. Obst. Gyn. Reprod. Biol., 2008, vol. 140, p. 33.CrossRefGoogle Scholar
  19. 19.
    Martinerie, L., Pussard, E., Foix-L’hélias, L., et al., Physiological partial aldosterone resistance in human newborns, Pediatr. Res. 2009, vol. 66, no. 3, p. 323.CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Gluckman, P.D. and Hanson, M.A., Developmental origins of disease paradigm: a mechanistic and evolutionary perspective, Pediatr. Res. 2004, vol. 56, no. 3, p. 311.CrossRefPubMedGoogle Scholar
  21. 21.
    Mannarino, S., Garofoli, F., Mongini, E. BNP concentrations and cardiovascular adaptation in preterm and fullterm newborn infants, Early Hum. Dev., 2010, vol. 86, no. 5, p. 295.CrossRefPubMedGoogle Scholar

Copyright information

© Pleiades Publishing, Inc. 2015

Authors and Affiliations

  • G. N. Chistyakova
    • 1
    Email author
  • I. A. Gazieva
    • 1
  • I. I. Remizova
    • 1
  1. 1.Department of Immunology and Clinical Microbiology, Ural Research Institute of Maternity and InfancyMinistry of Health of RussiaYekaterinburgRussia

Personalised recommendations